← Human Trials & Peer-Reviewed Studies

Acute Effects of Nicotine on Non-Drug-Related Reward in Smokers and Non-Smokers.

Plain-language guide to PMID 39908407 (2025): randomized controlled trial of Therapeutic nicotine (patch, non-peptide).

Key Facts

PMID
39908407
Journal
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Year
2025
Study type
Randomized Controlled Trial
Authors
Rycroft N et al. (4 authors)
DOI
10.1093/ntr/ntae278

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

An operant conditioning task (Applepicker) that required button clicks to find apples was completed twice, with and without a reward of 30 seconds of pre-prepared music for each reinforcer earned.

Measures taken were the number of apples found (reinforcers), number of clicks (responses), and time spent on the task (in seconds).

Why It Was Studied

This study aimed to explore whether nicotine delivered by oral spray can enhance responding to self-selected sensory rewards in both smokers and non-smokers.

Who Took Part

The age groups tagged for this paper are young adults, adults and middle-aged adults, both men and women.

How the Study Was Run

The researchers set it up as a randomized and placebo-controlled study.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

The comparison arm used a placebo, so changes seen with Therapeutic nicotine (patch, non-peptide) could be set against what happens without it.

What Was Measured

Topics PubMed links to this paper include Reward, Nicotine, Smokers, Non-Smokers, Substance Withdrawal Syndrome and Conditioning, Operant.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Therapeutic nicotine (patch, non-peptide).

The abstract goes on to report its results in about 9 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2025 (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.